Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood
暂无分享,去创建一个
H. Low | P. Meikle | D. Sviridov | A. Remaley | P. Nestel | G. Lancaster | Azusa Yamazaki | N. Mukhamedova | D. Sviridov | B. Vaisman | M. Tozuka | Gerard Pernes | R. Ohkawa | Mai Sasaoka | Yuna Horiuchi | Shao-Jui Lai | T. Kameda | Ying Fu | A. Murphy | Ayuko Hara | M. Ditiatkovski | G. Pernes | Hann Low | D. Sviridov | Y. Horiuchi
[1] H. Low,et al. Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood. , 2020, Journal of lipid research.
[2] H. Low,et al. Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood. , 2020, Journal of lipid research.
[3] T. Kubota,et al. Red blood cells participate in reverse cholesterol transport by mediating cholesterol efflux of high-density lipoprotein and apolipoprotein A-I from THP-1 macrophages , 2019, Biological chemistry.
[4] A. Gotto,et al. ABCA1-Derived Nascent High-Density Lipoprotein–Apolipoprotein AI and Lipids Metabolically Segregate , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[5] J. Wiśniewski,et al. Quantitative Analysis of Human Red Blood Cell Proteome. , 2017, Journal of proteome research.
[6] Ali Bijani,et al. Does Serum lipid profile differ in anemia and non-anemic older subjects? , 2017, Caspian journal of internal medicine.
[7] F. Kuypers,et al. Featured Article: Depletion of HDL3 high density lipoprotein and altered functionality of HDL2 in blood from sickle cell patients , 2017, Experimental biology and medicine.
[8] Mark T. Handley,et al. PLAA Mutations Cause a Lethal Infantile Epileptic Encephalopathy by Disrupting Ubiquitin-Mediated Endolysosomal Degradation of Synaptic Proteins , 2017, American journal of human genetics.
[9] F. Kuipers,et al. Transintestinal and Biliary Cholesterol Secretion Both Contribute to Macrophage Reverse Cholesterol Transport in Rats—Brief Report , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[10] S. Becker,et al. Cholesterol-mediated allosteric regulation of the mitochondrial translocator protein structure , 2017, Nature Communications.
[11] M. Nieuwdorp,et al. Transintestinal Cholesterol Transport Is Active in Mice and Humans and Controls Ezetimibe-Induced Fecal Neutral Sterol Excretion. , 2016, Cell metabolism.
[12] Lingshu Wang,et al. The Mechanism of Proinflammatory HDL Generation in Sickle Cell Disease Is Linked to Cell-Free Hemoglobin via Haptoglobin , 2016, PloS one.
[13] H. Low,et al. Cytomegalovirus Restructures Lipid Rafts via a US28/CDC42-Mediated Pathway, Enhancing Cholesterol Efflux from Host Cells. , 2016, Cell reports.
[14] Jonathan C. Cohen,et al. Crystal structure of the human sterol transporter ABCG5/ABCG8 , 2016, Nature.
[15] L. Addadi,et al. ABCA1 contributes to macrophage deposition of extracellular cholesterol , 2015, Journal of Lipid Research.
[16] Y. Yamauchi,et al. Deficiency in the Lipid Exporter ABCA1 Impairs Retrograde Sterol Movement and Disrupts Sterol Sensing at the Endoplasmic Reticulum*♦ , 2015, The Journal of Biological Chemistry.
[17] B. Wollscheid,et al. Deep sequencing and proteomic analysis of the microRNA-induced silencing complex in human red blood cells. , 2015, Experimental hematology.
[18] Hansford C. Hendargo,et al. Restoration of intracellular ATP production in banked red blood cells improves inducible ATP export and suppresses RBC-endothelial adhesion. , 2014, American Journal of Physiology. Heart and Circulatory Physiology.
[19] N. Sarrafzadegan,et al. Association of the Total Cholesterol Content of Erythrocyte Membranes with the Severity of Disease in Stable Coronary Artery Disease , 2014, Cholesterol.
[20] Jie Zhang,et al. Mannitol‐adenine‐phosphate: a novel solution for intraoperative blood salvage , 2014, Transfusion.
[21] J. Shaw,et al. Plasma lipid profiling in a large population-based cohort[S] , 2013, Journal of Lipid Research.
[22] S. Gummadi,et al. Biochemical evidence for lead and mercury induced transbilayer movement of phospholipids mediated by human phospholipid scramblase 1. , 2013, Chemical research in toxicology.
[23] A. Verhoeven,et al. The cholesterol content of the erythrocyte membrane is an important determinant of phosphatidylserine exposure. , 2012, Biochimica et biophysica acta.
[24] Y. Zhong,et al. Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin , 2012, Upsala journal of medical sciences.
[25] S. Turner,et al. Measurement of Reverse Cholesterol Transport Pathways in Humans: In Vivo Rates of Free Cholesterol Efflux, Esterification, and Excretion , 2012, Journal of the American Heart Association.
[26] Jonathan D. Smith,et al. Red Blood Cells Play a Role in Reverse Cholesterol Transport , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[27] N. Friedman,et al. Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis , 2011, Cell.
[28] P. Libby,et al. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial , 2010, The Lancet.
[29] A. Yamaguchi,et al. Characterization of the ATP-dependent Sphingosine 1-Phosphate Transporter in Rat Erythrocytes* , 2009, The Journal of Biological Chemistry.
[30] J. Volkmer,et al. Gene expression analysis of human red blood cells , 2009, International journal of medical sciences.
[31] J. Kaski,et al. Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability? , 2007, Journal of the American College of Cardiology.
[32] A. Hill,et al. Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-β Peptide Generation* , 2007, Journal of Biological Chemistry.
[33] P. Linsel-Nitschke,et al. Potential role of ABCA7 in cellular lipid efflux to apoA-I Published, JLR Papers in Press, November 1, 2004. DOI 10.1194/jlr.M400247-JLR200 , 2005, Journal of Lipid Research.
[34] J. Griffith,et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. , 2002, Journal of the American College of Cardiology.
[35] S. K. Kim,et al. Changes in serum lipid concentrations during iron depletion and after iron supplementation. , 2001, Annals of clinical and laboratory science.
[36] J. Peterson,et al. Prostaglandin Levels in Stimulated Macrophages Are Controlled by Phospholipase A2-activating Protein and by Activation of Phospholipase C and D* , 2001, The Journal of Biological Chemistry.
[37] K. Eckardt,et al. Cardiovascular consequences of renal anaemia and erythropoietin therapy. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[38] M C Phillips,et al. Use of cyclodextrins for manipulating cellular cholesterol content. , 1997, Journal of lipid research.
[39] D. Sviridov,et al. Efflux of Cellular Cholesterol and Phospholipid to Apolipoprotein A-I Mutants* , 1996, The Journal of Biological Chemistry.
[40] J. Frohlich,et al. Erythrocyte membrane alterations and plasma lipids in patients with chylomicronemia and in Tangier disease. , 1986, Clinical biochemistry.
[41] S. Quarfordt,et al. Quantitation of the in vitro free cholesterol exchange of human red cells and lipoproteins. , 1970, Journal of lipid research.
[42] C. B. Taylor,et al. The origin of plasma cholesterol and the rates of equilibration of liver, plasma, and erythrocyte cholesterol. , 1955, The Journal of laboratory and clinical medicine.
[43] R. Havel,et al. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.
[44] G. Anderluh,et al. Kinetics of cholesterol extraction from lipid membranes by methyl-beta-cyclodextrin--a surface plasmon resonance approach. , 2008, Biochimica et biophysica acta.